Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-DcR1/TRAILR3 Antibody-FITC (6O829) (Synonyms: tumor necrosis factor receptor superfamily member 10c, TRID|...)

Catalog No. TMAY-00795F Copy Product Info
🥰Excellent
Anti-DcR1/TRAILR3 Antibody-FITC (6O829) is a FITC-conjugated Rabbit antibody targeting DcR1/TRAILR3. Anti-DcR1/TRAILR3 Antibody-FITC (6O829) can be used in FCM.

Anti-DcR1/TRAILR3 Antibody-FITC (6O829)

Copy Product Info
🥰Excellent
Catalog No. TMAY-00795F
Synonyms tumor necrosis factor receptor superfamily member 10c, TRID, TRAIL-R3, TRAILR3, LIT, DCR1-TNFR, DCR1, CD263

Anti-DcR1/TRAILR3 Antibody-FITC (6O829) is a FITC-conjugated Rabbit antibody targeting DcR1/TRAILR3. Anti-DcR1/TRAILR3 Antibody-FITC (6O829) can be used in FCM.

Anti-DcR1/TRAILR3 Antibody-FITC
(6O829)
Pack SizePriceUSA StockGlobal StockQuantity
25 T$1057-10 days7-10 days
100 T$3297-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-DcR1/TRAILR3 Antibody-FITC (6O829) is a FITC-conjugated Rabbit antibody targeting DcR1/TRAILR3. Anti-DcR1/TRAILR3 Antibody-FITC (6O829) can be used in FCM.
Synonymstumor necrosis factor receptor superfamily member 10c, TRID, TRAIL-R3, TRAILR3, LIT, DCR1-TNFR, DCR1, CD263
Ig Type
Rabbit IgG
Clone
6O829
Reactivity
Human
Specificity
Human DcR1/TRAILR3
Verified Activity
Flow cytometric analysis of Human TNFRSF10C(CD263) expression on human whole blood granulocytes. Cells were stained with FITC-conjugated anti-Human TNFRSF10C(CD263). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable granulocytes.
Application
Recommended Dose
5 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesRabbit
ConstructionThis antibody was obtained from a rabbit immunized with purified, recombinant Human TRAILR3/TNFRSF10C (rh TRAILR3/TNFRSF10C; TMPY-04722; NP_003832.2; Met1-Pro235) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.09% sodium azide
Research BackgroundTNFRSF10C CNV in patients with CRC is associated with distant metastatic disease. A high frequency of CGI methylation in the TNFRSF10C promoter results in inactivation of the gene and enhancement of tumor growth in most PC cell lines (except CFPAC-1). Inactivation of TNFRSF10C by CpG island (CGI) hypermethylation can play an important role in PC progression and be potentially useful as a diagnostic marker and a new therapeutic approach for PC.
Related Conjugates and Formulations
Conjucates
FITC
Others Formats
Unconjugated/APC/PE
Antibody Types Available
4
Antigen Details
Immunogen
Recombinant Protein: Human TRAILR3/TNFRSF10C Protein (TMPY-04722)
Antigen Species
Human
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-DcR1/TRAILR3 Antibody-FITC (6O829) | purchase Anti-DcR1/TRAILR3 Antibody-FITC (6O829) | Anti-DcR1/TRAILR3 Antibody-FITC (6O829) cost | order Anti-DcR1/TRAILR3 Antibody-FITC (6O829)